RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
01 March 2024 - 11:05AM
(NASDAQ: RXST) RxSight, Inc., an ophthalmic
medical device company dedicated to providing high-quality
customized vision to patients following cataract surgery, today
announced plans to participate in the upcoming 34th Annual
Oppenheimer Healthcare Conference.
RxSight’s management is scheduled to participate in a fireside
chat on Wednesday, March 13, 2024, at 8:20 a.m. Pacific Time /
11:20 a.m. Eastern Time. Interested parties may access a live and
archived webcast of the presentation at:
https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated
to providing high-quality customized vision to patients following
cataract surgery. The RxSight® Light Adjustable Lens system,
comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight
Light Delivery Device (LDD™) and accessories, is the first and only
commercially available intraocular lens (IOL) technology that can
be adjusted after surgery, enabling doctors to customize and
deliver high-quality vision to patients after cataract surgery.
Additional information about RxSight can be found
at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:Oliver MoravcevicVP,
Investor Relationsomoravcevic@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Apr 2024 to May 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From May 2023 to May 2024